Letrozole SIE
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Letrozole SIE, covering 2026-04-02 to 2026-04-02. Get the full timeline:
Most recent: Clinical Trial Update: A Study to Investigate the Efficacy and Safety of Letrozole SIE Compared With Femara® (Both Combined With the CDK4/6 Inhibitor Ribociclib) in Postmenopausal Women With HR-Positive, HER2-Negative, Inoperable Locally Advanced or Metastatic Breast Cancer [Phase 3]